홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Chloroform → (R)-4-methyl-3-{4-[4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one hydrochloride

HRID 1804209
인쇄

반응식

HRID 1804209 반응식
[CH3:1][C@@H:2]1[CH2:6][O:5][C:4](=[O:7])[N:3]1[C:8]1[CH:16]=[CH:15][C:11]([C:12]([OH:14])=O)=[CH:10][CH:9]=1.[CH3:17][C:18]1[C:19]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[N:20][CH:21]=[C:22]([C:24]([F:27])([F:26])[F:25])[CH:23]=1.O.[Cl-].COC1N=C(OC)N=C([N+]2(C)CCOCC2)N=1.C(Cl)(Cl)[Cl:54]>O.CO>[ClH:54].[CH3:1][C@@H:2]1[CH2:6][O:5][C:4](=[O:7])[N:3]1[C:8]1[CH:9]=[CH:10][C:11]([C:12]([N:31]2[CH2:32][CH2:33][N:28]([C:19]3[C:18]([CH3:17])=[CH:23][C:22]([C:24]([F:27])([F:25])[F:26])=[CH:21][N:20]=3)[CH2:29][CH2:30]2)=[O:14])=[CH:15][CH:16]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 6212ChloroformHCID 231494114-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrateHCID 58484719(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acidHCID 584847291-(3-Methyl-5-trifluoromethylpyridin-2-yl)piperazine

생성물 1

HCID 67380787(R)-4-methyl-3-{4-[4-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one hydrochloride

시약·촉매·용매 2

HCID 887Methanol용매HCID 962Water용매

실험 절차

To a mixture of (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (664 mg) described in Preparation Example 37, 1-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine (736 mg) described in Preparation Example 51 and 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM) (1.2 g) were added chloroform (5 mL) and methanol (5 mL), and the mixture was stirred at room temperature overnight. Water was added to the reaction mixture, and the mixture was extracted with chloroform. The organic layer was washed with saturated brine, and the solvent was evaporated. The residue was purified by column chromatography (hexane:ethyl acetate). The obtained compound was dissolved in ethyl acetate (20 mL), 4N hydrogen chloride/ethyl acetate (1 mL) was added, and the mixture was filtered to give the title compound (310 mg).

후처리

  1. extractionthe mixture was extracted with chloroform
  2. washThe organic layer was washed with saturated brine
  3. customthe solvent was evaporated
  4. customThe residue was purified by column chromatography (hexane:ethyl acetate)
  5. dissolutionThe obtained compound was dissolved in ethyl acetate (20 mL)
  6. addition4N hydrogen chloride/ethyl acetate (1 mL) was added
  7. filtrationthe mixture was filtered

출처 및 근거

ORD 기록
ord-f4982234eebb423d8545c7716a34186f
출처 데이터셋
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08354401B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트